D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$9.6B |
| 2 |
Amazon
AMZN
|
+$1.56B |
| 3 |
NVIDIA
NVDA
|
+$1.1B |
| 4 |
Meta Platforms (Facebook)
META
|
+$924M |
| 5 |
SpaceX
SPCX
|
+$907M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$2.17B |
| 2 |
Broadcom
AVGO
|
+$1.53B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
TSMC
TSM
|
+$928M |
| 5 |
Texas Instruments
TXN
|
+$904M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 33.7% |
| 2 | Technology | 18.77% |
| 3 | Financials | 8.35% |
| 4 | Healthcare | 7.91% |
| 5 | Consumer Discretionary | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3326
Huazhu Hotels Group
HTHT
$14.6B
| $1.5M | ﹤0.01% |
+36,068
| New | +$1.72M |
2026 Q2
0 quarters
|
|
3327
Balchem Corp
BCPC
$5.64B
| $1.5M | ﹤0.01% |
8,897
-31,371
| -78% | -$5.21M |
2022 Q1
17 quarters
|
|
3328
CALL
Constellation Brands
STZ
$23.5B
| $1.5M | ﹤0.01% |
10,800
-26,800
| -71% | -$3.98M |
2025 Q2
4 quarters
|
|
3329
Ginkgo Bioworks
DNA
$673M
| $1.5M | ﹤0.01% |
151,356
+124,187
| +457% | +$1.04M |
2025 Q4
2 quarters
|
|
3330
Peace Acquisition Corp
PECE
$84.6M
| $1.5M | ﹤0.01% |
+151,000
| New | +$1.5M |
2026 Q2
0 quarters
|
|
3331
Invest Green Acquisition Corp
IGAC
$242M
| $1.49M | ﹤0.01% |
149,197
+48,400
| +48% | +$483K |
2026 Q1
1 quarter
|
|
3332
PUT
Altria Group
MO
$124B
| $1.49M | ﹤0.01% |
20,700
-73,800
| -78% | -$5.15M |
2018 Q1
33 quarters
|
|
3333
Invesco QQQ Trust
QQQ
$475B
| $1.49M | ﹤0.01% |
+2,022
| New | +$1.39M |
2026 Q2
0 quarters
|
|
3334
PUT
Materion
MTRN
$4.61B
| $1.49M | ﹤0.01% |
+5,000
| New | +$1.05M |
2026 Q2
0 quarters
|
|
3335
Inovio Pharmaceuticals
INO
$92.8M
| $1.49M | ﹤0.01% |
1,351,656
-861,163
| -39% | -$1.02M |
2025 Q3
3 quarters
|
|
3336
Eos Energy Enterprises
EOSE
$630M
| $1.49M | ﹤0.01% |
252,636
+105,197
| +71% | +$732K |
2025 Q4
2 quarters
|
|
3337
American Vanguard Corp
AVD
$30.4M
| $1.48M | ﹤0.01% |
530,006
+26
| +0% | +$71 |
2021 Q2
20 quarters
|
|
3338
Choiceone Financial
COFS
$512M
| $1.48M | ﹤0.01% |
43,598
-4,013
| -8% | -$125K |
2025 Q4
2 quarters
|
|
3339
Nelnet
NNI
$4.39B
| $1.48M | ﹤0.01% |
11,109
-9,271
| -45% | -$1.23M |
2013 Q2
52 quarters
|
|
3340
PUT
PennyMac Financial
PFSI
$3.31B
| $1.48M | ﹤0.01% |
+17,000
| New | +$1.48M |
2026 Q2
0 quarters
|
|
3341
Onity Group
ONIT
$215M
| $1.48M | ﹤0.01% |
37,225
+12,553
| +51% | +$495K |
2025 Q3
3 quarters
|
|
3342
Benchmark Electronics
BHE
$2.36B
| $1.48M | ﹤0.01% |
14,989
-41,931
| -74% | -$3.34M |
2025 Q1
5 quarters
|
|
3343
DELISTED
RE/MAX Holdings
RMAX
| $1.48M | ﹤0.01% |
149,751
-318,080
| -68% | -$2.78M |
2023 Q3
11 quarters
|
|
3344
PUT
Equifax
EFX
$21.4B
| $1.48M | ﹤0.01% |
+9,300
| New | +$1.59M |
2026 Q2
0 quarters
|
|
3345
Alamo Group
ALG
$1.78B
| $1.48M | ﹤0.01% |
8,973
+1,000
| +13% | +$162K |
2023 Q1
13 quarters
|
|
3346
Rising Dragon Acquisition Corp
RDAC
$29.2M
| $1.47M | ﹤0.01% |
273,125
| – | – |
2024 Q4
6 quarters
|
|
3347
PUT
Macy's
M
$6.29B
| $1.47M | ﹤0.01% |
62,600
-315,000
| -83% | -$6.59M |
2013 Q2
52 quarters
|
|
3348
PUT
BlackSky Technology
BKSY
$719M
| $1.47M | ﹤0.01% |
52,800
| – | – |
2025 Q3
3 quarters
|
|
3349
FIVE9
FIVN
$2.81B
| $1.47M | ﹤0.01% |
69,058
-6,766
| -9% | -$134K |
2024 Q2
8 quarters
|
|
3350
CALL
MetLife
MET
$62.8B
| $1.47M | ﹤0.01% |
+17,400
| New | +$1.4M |
2026 Q2
0 quarters
|
|
Similar funds
D.E. Shaw & Co's Q2 2026 Portfolio in Review
As of Q2 2026, D.E. Shaw & Co held 5,360 positions worth $210B, up 26% from $166B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
D.E. Shaw & Co deployed $8.31B of net new capital in Q2 2026, opening 872 new positions and adding to 1,718 existing holdings. Its largest new stake was SpaceX: 5,340,000 shares worth $912M.
By sector, the portfolio is most concentrated in Miscellaneous at 34% of assets, up from 30% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Micron Technology, an estimated $2.17B trimmed.
- D.E. Shaw & Co's largest Q2 2026 buy was SpaceX: 5,340,000 shares worth $912M.
- D.E. Shaw & Co added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $9.6B increase.
- D.E. Shaw & Co's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $2.17B.
- D.E. Shaw & Co fully exited Automatic Data Processing in Q2 2026, selling an estimated $241M.
- D.E. Shaw & Co's ten largest holdings make up 15% of its $210B portfolio in Q2 2026.
- D.E. Shaw & Co opened 872 new positions and closed 527 in Q2 2026.
- D.E. Shaw & Co's portfolio value rose 26% quarter-over-quarter to $210B.
Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.